IMEP (chemotherapy)

IMEP (chemotherapy)

IMEP is a chemotherapy regimen for treatment of cancer, including leukemia and lymphoma. It is an acronym for four drugs used in the treatment:

• Idarubicin
• Methotrexate
• Etoposide
• Prednisolone

Idarubicin

Idarubicin is an anthracycline antineoplastic agent that is used in the treatment of a wide range of cancers, including leukemia, lymphoma, and breast cancer. It works by intercalating DNA, disrupting the function of topoisomerase II, and generating free radicals that damage DNA.

Methotrexate

Methotrexate is an antimetabolite and antifolate drug used in treatment of cancer and autoimmune diseases. It works by inhibiting the metabolism of folic acid, which is necessary for the synthesis of DNA, RNA, and proteins.

Etoposide

Etoposide is a semisynthetic derivative of podophyllotoxin used in the treatment of certain neoplastic diseases. It is highly active against testicular and small cell lung cancer. It works by inhibiting the enzyme topoisomerase II, leading to breakage of DNA strands.

Prednisolone

Prednisolone is a synthetic glucocorticoid drug that is used for suppressing the immune response and inflammation. It is used in the treatment of a variety of diseases, including certain types of cancer, autoimmune diseases, and inflammatory conditions.

See also

• Chemotherapy
• Cancer
• Leukemia
• Lymphoma

IMEP (chemotherapy) Resources
Latest articles Most recent articles Ongoing trials	Wikipedia